source
- Merck and Moderna present Phase 3 cancer vaccine data at ESMO26 amid Treasury proposal on China investmentEndpoints Weekly reporter Nicole DeFeudis writes from Madrid during the ESMO26 meeting. The most anticipated presentation was a Phase 3 study of a cancer vaccine jointly developed by Merck and Mod…
- AstraZeneca, Lilly and Bayer unveil new strategies at ESMO 2026 in MadridAt the European Society for Medical Oncology (ESMO) congress in Madrid, nearly 40,000 delegates gathered for the five-day meeting. AstraZeneca said it is evaluating the use of its immunotherapy Ke…